Yahoo Web Search

Search results

1. scholar.google.com › citations‪Michael Y.T. Chow‬ - ‪Google Scholar‬

   scholar.google.com › citations

   • Cached

   ‪University College London School of Pharmacy‬ - ‪‪Cited by 2,440‬‬ - ‪Pharmaceutics‬ - ‪Pulmonary Drug Delivery‬

2. www.researchgate.net › Michael-YT-Chow-59216217Michael Y.T. Chow's research works | The School of Pharmacy ...

   www.researchgate.net › Michael-YT-Chow-59216217

   Michael Y.T. Chow's 33 research works with 1,650 citations and 21,161 reads, including: Delivery technology of inhaled therapy for asthma and COPD

3. pubmed.ncbi.nlm.nih.gov › 32893004Inhaled RNA Therapy: From Promise to Reality - PubMed

   pubmed.ncbi.nlm.nih.gov › 32893004

   Abstract. RNA-based medicine is receiving growing attention for its diverse roles and potential therapeutic capacity. The largest obstacle in its clinical translation remains identifying a safe and effective delivery system.

   • Author: Michael Y.T. Chow, Michael Y.T. Chow, Yingshan Qiu, Jenny K.W. Lam

   • Publish Year: 2020

4. www.cmu.edu › tepper › faculty-and-researchFaculty Profiles - Tepper School of Business - Carnegie ...

   www.cmu.edu › tepper › faculty-and-research

   • Cached

   Professor of Engineering and Public Policy; Electrical and Computer Engineering and Joint Appointment at Tepper School of Business. Read full bio

5. europepmc.org › article › MEDInhaled RNA Therapy: From Promise to Reality. - Europe PMC

   europepmc.org › article › MED

   • Cached

   Sep 4, 2020 · The studies are classified by (A) type of delivery vector; (B) disease model used; (C) administration method used in animal studies; and (D) RNA type. The classification was done independently by Y.Q. and M.C. and was cross-validated by J.K.W.L. Abbreviation: LIRI, lung ischemia–reperfusion injury.

6. pubmed.ncbi.nlm.nih.gov › 33705876Dry powder pharmaceutical biologics for inhalation therapy

   pubmed.ncbi.nlm.nih.gov › 33705876

   Pulmonary delivery of therapeutic biologics enables the potential for safe and effective treatment option for respiratory diseases due to high bioavailability while minimizing absorption into the systemic circulation, reducing off-target toxicity to other organs.

7. pubmed.ncbi.nlm.nih.gov › 37524490Delivery technology of inhaled therapy for asthma and COPD

   pubmed.ncbi.nlm.nih.gov › 37524490

   This chapter provides an overview of inhaled therapy for the management of asthma and COPD. The operation principles, merits and limitations of different delivery technologies are examined. Looking ahead, the challenges of delivering novel therapeutics such as biologics through the pulmonary route are also discussed.